Quick Answer
GRI Bio, Inc. reported Research And Development Expense of $6.82 million for the year ending 2025.
- GRI Bio, Inc. showed an increase of +81.0% in Research And Development Expense from 2024 to 2025.
- This data is from GRI Bio, Inc.'s annual report (Form 10-K), filed with the SEC on January 30, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), GRI Bio, Inc.'s Research And Development Expense has grown by 83.9%.
- Historical annual values: Fiscal year 2025: $6.82 million | Fiscal year 2024: $3.77 million | Fiscal year 2023: $3.23 million | Fiscal year 2022: $242.0 thousand | Fiscal year 2021: $5.19 million | Fiscal year 2020: $3.71 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: